Russell Investments Group
SQZ

Russell Investments Group’s SQZ Biotechnologies Company SQZ Stock Holding History

Russell Investments Group’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8,192
Closed -$26K – 3006
2022
Q2 		$26K Buy
+8,192
New +$29.5K ﹤0.01% 2778

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Russell Investments Group's SQZ Position: Q3 2022 in Review

Russell Investments Group sold out of SQZ Biotechnologies Company (SQZ) in Q3 2022, closing a stake of 8,192 shares — an estimated $26K sold.

Russell Investments Group first reported a position in SQZ in Q2 2022 and held it in 1 quarter. The position peaked at $26K in Q2 2022. 48 funds tracked by Wall St. Rank hold SQZ as of Q3 2022.

  • Russell Investments Group reported no remaining SQZ Biotechnologies Company position as of Q3 2022 after selling out during the quarter.
  • Russell Investments Group sold 8,192 SQZ Biotechnologies Company shares in Q3 2022, an estimated $26K.
  • Russell Investments Group first reported a position in SQZ Biotechnologies Company in Q2 2022 and held it in 1 quarter.
  • Russell Investments Group's SQZ Biotechnologies Company position peaked at $26K in Q2 2022.
  • 48 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2022.

Based on Russell Investments Group's 13F filing for Q3 2022, filed 4 Nov 2022.